During the past decade, Central Coast Medical Oncology Corporation conducted 10 clinical trials. In the 10-year time frame, 10 clinical trials started and 35 clinical trials were completed, i.e. on average, 350% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 10 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Coast Medical Oncology Corporation" #1 sponsor was "Pfizer" with 7 trials, followed by "Novartis Pharmaceuticals" with 6 trials sponsored, "Translational Oncology Research International" with 4 trials sponsored, "Celgene" with 3 trials sponsored and "Clovis Oncology, Inc." with 3 trials sponsored. Other sponsors include 25 different institutions and companies that sponsored additional 26 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Coast Medical Oncology Corporation" #1 collaborator was "Genentech, Inc." with 4 trials as a collaborator, "National Cancer Institute (NCI)" with 2 trials as a collaborator, "University of California, Los Angeles" with 2 trials as a collaborator, "ARMO BioSciences" with 1 trials as a collaborator and "AstraZeneca" with 1 trials as a collaborator. Other collaborators include 7 different institutions and companies that were collaborators in the rest 17 trials.

According to Clinical.Site data, the most researched conditions in "Central Coast Medical Oncology Corporation" are "Breast Cancer" (13 trials), "Metastatic Breast Cancer" (5 trials), "Breast Neoplasms" (4 trials), "Multiple Myeloma" (3 trials) and "Non-Small Cell Lung Cancer" (3 trials). Many other conditions were trialed in "Central Coast Medical Oncology Corporation" in a lesser frequency.

Most popular intervention types in "Central Coast Medical Oncology Corporation" are "Drug" (51 trials), "Biological" (8 trials) and "Other" (3 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "Rituximab" (5 trials), "Cyclophosphamide" (4 trials), "Bevacizumab" (3 trials) and "Carboplatin" (3 trials). Other intervention names were less common.

The vast majority of trials in "Central Coast Medical Oncology Corporation" are 33 trials for "All" genders, 18 trials for "Female" genders and 2 trials for "Male" genders.

Currently, there are NaN active trials in "Central Coast Medical Oncology Corporation". undefined are not yet recruiting, undefined are recruiting, 3 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 37 completed trials in Central Coast Medical Oncology Corporation, undefined suspended trials, and 13 terminated clinical trials to date.

Out of the total trials that were conducted in Central Coast Medical Oncology Corporation, 5 "Phase 1" clinical trials were conducted, 31 "Phase 2" clinical trials and 23 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".